TAVR in the Different Types of Aortic Stenosis

Aortic stenosis (AS) is classified according to gradient into high flow and high gradient (D1), low flow-low gradient with reduced ejection fraction (D2), and paradoxical low flow-low gradient with conserved ejection fraction (D3).

Nuevas guías de valvulopatías con actualizaciones clave en TAVI e insuficiencia mitral

D3 AS is characterized by ≥50% ejection fraction, but with systolic volume index ≤35 ml/min.

Post TAVR evolution of D2 and D3 AS, as regards quality of life, has not been thoroughly looked into by the existing studies. 

This study looked at 634 patients, 328 presenting D1, 76 with D2 and 230 with D3 AS.

Mean age was 77, 60% were men and STS was 6.6%, with no significant differences in comorbidities, except in those with D2 AS, who presented higher incidence of cardiac failure, functional class IV, atrial fibrillation, definite pacemaker implantation, higher need of cardio-defibrillator prior TAVR and lower ejection fraction. 

At 30 days, those with D1 AS showed higher mortality (2.5% vs. 0% vs. 0%, p=0.03 for D1, D2 and D3 AS respectively), with no differences in stroke, major bleeding, or dialysis need. The need for definite pacemaker implantation was higher among D2 AS patients.

Read also: Physiologically Significant Obstructions in the Left Main Coronary Artery: Revascularizing vs. Deferring.

After one year followup, there were no significant differences in mortality, stroke, MI, major bleeding, need for pacemaker implantation or readmission. All 3 groups experienced improved functional class and quality of life. D2 AS patients also showed improved ejection fraction. 

Conclusion

Patients with D2 AS experienced significant improvement in ejection fraction and quality of life at 30 days and one year. The need for pacemaker implantation after TAVR was higher than in the other subtypes, while stroke and mortality were lower than expected, which supports the use of TAVR in this high risk group. 

Dr. Carlos Fava - Consejo Editorial SOLACI

Dr. Carlos Fava.
Member of the Editorial Board of SOLACI.org.

Original Title: Transcatheter Aortic Valve Replacement Improves Quality of Life and Ventricular Function With Low-Flow/Low-Gradient Aortic Stenosis

Reference: Kelley N. Benck , et al. JSCAIhttps://doi.org/10.1016/j.jscai.2023.101266. 


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

T-TEER: Beyond Traditional Pulmonary Hypertension Thresholds

Significant tricuspid regurgitation (TR) is associated with progressive functional deterioration, heart failure (HF) hospitalizations, and increased mortality. In recent years, transcatheter tricuspid edge-to-edge repair...

Is left atrial appendage closure safe in patients with reduced ejection fraction?

Patients with heart failure with reduced ejection fraction (HFrEF) were excluded from the major randomized trials evaluating percutaneous left atrial appendage closure (LAAC), and...

Left Atrial Appendage Closure in Spain: Sustained Growth and Favorable Real-World Outcomes

Oral anticoagulation remains the standard treatment for stroke prevention in patients with atrial fibrillation. However, many patients have a high bleeding risk or contraindications...

HERA-TAVI: Intra-Annular vs Supra-Annular Valves in TAVI

 The HERA-TAVI study is an international multicenter registry that compared the clinical and hemodynamic outcomes of contemporary self-expanding transcatheter heart valves with intra-annular (IA)...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img
Jornadas Guatemala 2026

Recent Articles

Plaque Ruptures in Non-Culprit Arteries: Follow-Up With Intravascular Imaging

Plaque rupture remains one of the most important pathophysiological mechanisms in acute coronary syndromes. However, not all ruptures manifest clinically as ischemia, myocardial infarction,...

Drug-Eluting Stents in Peripheral Arterial Disease: When Should They Be Used?

Peripheral drug-eluting stents have transformed the treatment of peripheral arterial disease by reducing restenosis rates and the need for repeat interventions. However, the emergence...

OCT-Detected High-Risk Plaques Predict Recurrent Events After Myocardial Infarction

After a myocardial infarction (MI), non-culprit lesions are often deferred when they are not flow-limiting (negative FFR). However, these lesions continue to represent an...